Free Trial
NASDAQ:SLSN

Solesence Q2 2025 Earnings Results & Report

Solesence logo
$0.86 +0.03 (+3.44%)
As of 02:27 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Solesence reported Q2 2025 earnings on July 31, 2025. The company reported EPS of $0.04, while revenue was $20.36 million.

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
After Market Closes

Solesence EPS Results

Actual EPS
$0.04
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Solesence Revenue Results

Actual Revenue
$20.36 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Solesence Q2 2025 Earnings FAQ

Solesence (NASDAQ:SLSN) reported earnings of $0.04 per share for Q2 2025. The report was announced on Thursday, July 31, 2025.

Solesence reported revenue of $20.36 million for Q2 2025.

Solesence Earnings Headlines

Solesence, Inc. Charts Rebound Amid Mixed Earnings
Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
Solésence Reports Second Quarter 2026 Financial Results
See More Solesence Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Solesence? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Solesence and other key companies, straight to your email.

About Solesence

Solesence (NASDAQ:SLSN) is a skincare company focused on developing and commercializing science-based products designed to support skin health and improve the appearance of skin. The company combines cosmetic, dermatological and photoprotection research to create topical formulations for consumers and professional skincare markets.

Its product offerings include skincare solutions intended to address concerns such as visible signs of aging, skin discoloration and damage associated with environmental exposure. Solesence emphasizes proprietary formulations, active ingredients and evidence-based product development across categories that may include daily skincare and sun protection.

The company serves the beauty, wellness and medical aesthetics sectors through brand, retail and professional distribution channels. Solesence is headquartered in the United States and markets its products to customers in domestic and international markets.

View Solesence Profile